BACKGROUND: Local production of IgA and IgE in the airways has been proposed to be an important event in both immune protection from pathogens and the pathogenesis of airway allergic diseases. OBJECTIVE: The objective of this study was to investigate the production of B cell-activating factor of the TNF family (BAFF), an important regulator of B-cell survival and immunoglobulin class-switch recombination, in bronchoalveolar lavage (BAL) fluid after segmental allergen challenge of allergic subjects. METHODS: Segmental allergen challenge with saline or allergen was performed in 16 adult allergic subjects. BAL was performed at both saline- and allergen-challenged sites 20 to 24 hours after challenge. Concentrations of B cell-active cytokines, including BAFF, IL-6, and IL-13, were measured by using specific ELISA and cytometric bead array assays. RESULTS: Levels of BAFF protein were significantly increased in BAL fluid after allergen challenge (53.8 pg/mL [range, 0-407.4 pg/mL], P = .001) compared with those at saline-challenged sites (0 pg/mL [0-34.7 pg/mL]). In the BAL fluid after allergen challenge, BAFF levels were significantly correlated with absolute numbers of total cells (r = 0.779, P < .001), lymphocytes (r = 0.842, P < .001), neutrophils (r = 0.809, P < .001), and eosinophils (r = 0.621, P = .010) but did not correlate with macrophages. Normalization to albumin indicated that BAFF production occurred locally in the airways. BAFF levels were also significantly correlated with the other B cell-activating cytokines IL-6 (r = 0.875, P < .001) and IL-13 (r = 0.812, P < .001). CONCLUSION: The antigen-induced production of BAFF in the airway might contribute to local class-switch recombination and immunoglobulin synthesis by B cells.
BACKGROUND: Local production of IgA and IgE in the airways has been proposed to be an important event in both immune protection from pathogens and the pathogenesis of airway allergic diseases. OBJECTIVE: The objective of this study was to investigate the production of B cell-activating factor of the TNF family (BAFF), an important regulator of B-cell survival and immunoglobulin class-switch recombination, in bronchoalveolar lavage (BAL) fluid after segmental allergen challenge of allergic subjects. METHODS: Segmental allergen challenge with saline or allergen was performed in 16 adult allergic subjects. BAL was performed at both saline- and allergen-challenged sites 20 to 24 hours after challenge. Concentrations of B cell-active cytokines, including BAFF, IL-6, and IL-13, were measured by using specific ELISA and cytometric bead array assays. RESULTS: Levels of BAFF protein were significantly increased in BAL fluid after allergen challenge (53.8 pg/mL [range, 0-407.4 pg/mL], P = .001) compared with those at saline-challenged sites (0 pg/mL [0-34.7 pg/mL]). In the BAL fluid after allergen challenge, BAFF levels were significantly correlated with absolute numbers of total cells (r = 0.779, P < .001), lymphocytes (r = 0.842, P < .001), neutrophils (r = 0.809, P < .001), and eosinophils (r = 0.621, P = .010) but did not correlate with macrophages. Normalization to albumin indicated that BAFF production occurred locally in the airways. BAFF levels were also significantly correlated with the other B cell-activating cytokines IL-6 (r = 0.875, P < .001) and IL-13 (r = 0.812, P < .001). CONCLUSION: The antigen-induced production of BAFF in the airway might contribute to local class-switch recombination and immunoglobulin synthesis by B cells.
Authors: Emanuela Castigli; Stephen A Wilson; Lilit Garibyan; Rima Rachid; Francisco Bonilla; Lynda Schneider; Raif S Geha Journal: Nat Genet Date: 2005-07-10 Impact factor: 38.330
Authors: Kai Bratke; Marek Lommatzsch; Peter Julius; Michael Kuepper; Hans-Dieter Kleine; Werner Luttmann; J Christian Virchow Journal: Thorax Date: 2006-08-23 Impact factor: 9.139
Authors: Pooja Takhar; Christopher J Corrigan; Lyn Smurthwaite; Brian J O'Connor; Stephen R Durham; Tak H Lee; Hannah J Gould Journal: J Allergy Clin Immunol Date: 2007-01 Impact factor: 10.793
Authors: Hannah J Gould; Pooja Takhar; Helen E Harries; Stephen R Durham; Christopher J Corrigan Journal: Trends Immunol Date: 2006-09-01 Impact factor: 16.687
Authors: Kathryn L Pothoven; James E Norton; Kathryn E Hulse; Lydia A Suh; Roderick G Carter; Erin Rocci; Kathleen E Harris; Stephanie Shintani-Smith; David B Conley; Rakesh K Chandra; Mark C Liu; Atsushi Kato; Nirmala Gonsalves; Leslie C Grammer; Anju T Peters; Robert C Kern; Paul J Bryce; Bruce K Tan; Robert P Schleimer Journal: J Allergy Clin Immunol Date: 2015-04-01 Impact factor: 10.793
Authors: Elizabeth A Erwin; Hayley R James; Heather M Gutekunst; John M Russo; Kelly J Kelleher; Thomas A E Platts-Mills Journal: Ann Allergy Asthma Immunol Date: 2010-06 Impact factor: 6.347
Authors: Jennifer Lavin; Jin-Young Min; Alcina K Lidder; Julia He Huang; Atsushi Kato; Kent Lam; Eric Meen; Joan S Chmiel; James Norton; Lydia Suh; Mahboobeh Mahdavinia; Kathryn E Hulse; David B Conley; Rakesh K Chandra; Stephanie Shintani-Smith; Robert C Kern; Robert P Schleimer; Bruce K Tan Journal: Laryngoscope Date: 2017-03-21 Impact factor: 3.325
Authors: Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan Journal: J Clin Invest Date: 2013-11 Impact factor: 14.808
Authors: Robert P Schleimer; Atsushi Kato; Anju Peters; David Conley; Jean Kim; Mark C Liu; Kathleen E Harris; Douglas A Kuperman; Rakesh Chandra; Silvio Favoreto; Pedro C Avila; Leslie C Grammer; Robert C Kern Journal: Proc Am Thorac Soc Date: 2009-05-01